Cemtrex - CETX Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cemtrex in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CETX shares.
View CETX analyst ratings or view top-rated stocks.

1 Wall Street research analysts have issued 12 month price targets for Cemtrex's stock. Their CETX share price forecasts range from $23.00 to $23.00. On average, they expect the company's stock price to reach $23.00 in the next twelve months. This suggests a possible upside of 168.7% from the stock's current price.
View analysts price targets for CETX or view top-rated stocks among Wall Street analysts.

Cemtrex's stock was trading at $4.3295 at the beginning of the year. Since then, CETX shares have increased by 97.7% and is now trading at $8.56.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 15th 2023.
View our CETX earnings forecast.

Cemtrex, Inc. (NASDAQ:CETX) announced its earnings results on Tuesday, February, 14th. The industrial products company reported ($3.99) earnings per share for the quarter, missing the consensus estimate of ($1.71) by $2.28. The industrial products company earned $11.97 million during the quarter, compared to analysts' expectations of $13.30 million. Cemtrex had a negative net margin of 28.74% and a negative trailing twelve-month return on equity of 77.83%.

Cemtrex's stock reverse split on Monday, January 23rd 2023. The 1-35 reverse split was announced on Monday, January 23rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cemtrex investors own include Buckeye Partners (BPL), Nokia Oyj (NOK), Vaxart (VXRT), Aethlon Medical (AEMD), Inpixon (INPX), VBI Vaccines (VBIV), Co-Diagnostics (CODX), Digital Ally (DGLY), Biocept (BIOC) and OpGen (OPGN).

Cemtrex trades on the NASDAQ under the ticker symbol "CETX."

Shares of CETX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CETX stock can currently be purchased for approximately $8.56.

Cemtrex (NASDAQ:CETX) has a market capitalization of $7.02 million and generates $50.28 million in revenue each year. The industrial products company earns $-13,020,000.00 in net income (profit) each year or ($20.1282) on an earnings per share basis.

The company employs 344 workers across the globe.

Cemtrex's mailing address is 276 GREENPOINT AVE. BLD 8 SUITE 208, BROOKLYN NY, 11222. The official website for the company is www.cemtrex.com. The industrial products company can be reached via phone at (631) 756-9116, via email at investors@cemtrex.com, or via fax at 631-420-4985.